Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses

Current Opinion in Immunology

Volumn 8, Issue 4, 1996, Pages 472-477

  Kägi, David ^a   Hengartner, Hans ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; INTERFERON; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CYTOPATHOGENIC EFFECT; CYTOTOXIC T LYMPHOCYTE; INFLUENZA VIRUS; MOUSE; NONHUMAN; REVIEW; SEMLIKI FOREST ALPHAVIRUS; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS MENINGITIS;

EID: 0030218260     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80033-1     Document Type: Article

References (49)

1. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond (Biol). 147:1957;258-267.
2. Lehmann-Grube F, Moskophidis D, Löhler J. Recovery from acute virus infection: role of cytotoxic T lymphocytes in the elimination of lymphocytic chriomeningitis virus from spleens of mice. Ann NY Acad Sci. 532:1988;238-256.
3. Oldstone MBA, Blount P, Southern PJ, Lampert PW. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature. 321:1986;239-243.
4. Kägi D, Ledermann B, Bürki K, Seiler P, Odermatt B, Olsen KJ, Podack E, Zinkernagel RM, Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:1994;31-37.
5. Walsh CM, Matloubian M, Liu C-C, Ueda R, Kurahara CG, Christensen JL, Huang MTF, Young JD-E, Ahmed R, Clark WR. Immune function in mice lacking the perforin gene. Proc Natl Acad Sci USA. 91:1994;10854-10858.
6. 2+- independent T cell mediated cytotoxity. J Exp Med. 177:1993;195-200.
7. Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science. 265:1994;528-530.
8. Kojima H, Shinohara N, Hanaoka S, Someya-Shirota Y, Takagaki Y, Ohno H, Saito T, Katayama T, Yagita H, Okumura K, et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity. 1:1994;357-364.
9. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature. 370:1994;650-652.
10. Podack ER, Hengartner H, Lichtenheld MG. A central role of perforin in cytolysis. Annu Rev Immunol. 9:1991;129-157.
11. Nagata S, Golstein P. The Fas death factor. of special interest Science. 267:1995;1449-1462 This paper, along with [10], discusses two molecules, perforin and Fas, that are crucially involved in the two separate pathways of T-cell-mediated cytotoxicity.
12. Zinkernagel RM, Althage A. Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled. J Exp Med. 145:1977;644-651.
13. Buchmeier MJ, Welsh RM, Dutko FJ, Oldstone MBA. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol. 30:1980;275-331.
14. Kägi D, Seiler P, Pavlovic J, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. of special interest Eur J Immunol. 25:1995;3256-3262 This study defines the different requirements for perforin- and Fas-dependent cytotoxicity in control of LCMV, VV, VSV and SFV infection.
15. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:1992;314-317.
16. Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, Tough T, Gibson M, Davis-Smith T, Smith CA, Hunter K, et al. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity. 1:1994;131-136.
17. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:1994;969-976.
18. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS, Pickup DJ. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell. 69:1992;597-604.
19. Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 375:1995;78-80.
20. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Dröge W, Krammer PH, Fiers W, Schulze-Osthoff K. Requirement of an ICE/CED-3 protease for Fas/Apo-1-mediated apopotosis. Nature. 375:1995;81-83.
21. Schulz M, Schuurman H-J, Joergensen J, Steiner C, Meerloo T, Kägi D, Hengartner H, Zinkernagel RM, Schreier MH, Bürki K, Ledermann B. Acute rejection of vascular hart allografts by perforin-deficient mice. Eur J Immunol. 25:1995;474-480.
22. Walsh CM, Hayashi F, Saffran DC, Ju S-T, Berke G, Clark WR. Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection. J Immunol. 156:1996;1436-1441.
23. Russel JH, Rush B, Weaver C, Wang R. Mature T cells of autoimmune Ipr/Ipr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA. 90:1993;4409-4413.
24. Crispe IN. Fatal interaction: Fas-induced apoptosis of mature T cells. Immunity. 1:1994;347-349.
25. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today. 16:1995;569-574.
26. Singer GG, Abbas AK. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1:1994;365-371.
27. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J. Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med. 183:1996;657-661.
28. Kündig T, Castelmur I, Bachmann MF, Abraham D, Binder D, Hengartner H, Zinkernagel RM. Fewer protective cytotoxic T cell epitopes than T helper cell epitopes on vesicular stomatitis virus. J Virol. 67:1993;3680-3683.
29. + T cells correlating with cytotoxic activity in vitro are more efficient in anti-vaccinia virus protection than CD4-dependent interleukins. J Immunol. 146:1991;4301-4307.
30. Ramsay AJ, Ruby J, Ramshaw IA. The case for cytokines as effector molecules in the resolution of virus infection. Immunol Today. 14:1993;155-157.
31. Ando K, Guidotti G, Cerny A, Ishikawa T, Chisari FV. CTL access to tissue antigen is restricted in vivo. J Immunol. 153:1994;482-488.
32. + T cell mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol. 24:1994;3068-3072.
33. Morris AG, Lin Y-L, Askonas BA. Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell. Nature. 295:1982;150-152.
34. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dyamics in vivo: virion clearance rate, infected cell lifespan and viral generation time. Science. 271:1996;1582-1586.
35. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. of special interest Nat Med. 1:1995;59-64 The authors report evidence that protection against infection of highly HIV exposed individuals may correlate with their ability to mount a CTL response.
36. + nef-specific cytotoxic T cells in vaccinated macaques. Nat Med. 1:1995;1167-1173.
37. Meltzer MS, Nakamura M, Hansen BD, Turpin JA, Kalter DC, Gendelman HE. Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res Hum Retroviruses. 6:1990;967-972.
38. Hirsch MS, Nahmias AJ, Murphy FA, Kramer JH. Cellular immunity in vaccinia infection of mice: anti-thymocyte serum effects on primary and secondary responsiveness. J Exp Med. 128:1968;121-131.
39. Wong GHW, Goeddell DV. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature. 323:1986;819-822.
40. Müller U, Steinhoff U, Reis LFL, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 264:1994;1918-1921.
41. Dietzschold B, Schneider LG, Cox JH. Serological characterization of the three major proteins of vesicular stomatitis virus. J Virol. 14:1974;1-7.
42. Zinkernagel RM, Rosenthal KL. Experiments and speculation on antiviral specificity of T and B cells. Immunol Rev. 58:1981;131-155.
43. Lefrançois L, Lyles DS. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology. 121:1982;157-167.
44. Griffin DE, Levine B, Tyor WR, Irani DN. The immune response in viral encephalitis. Semin Immunol. 4:1992;111-119.
45. + T cells. J Exp Med. 174:1991;875-880.
46. b gene. J Immunol. 155:1995;2955-2959.
47. Marker O, Volkert M. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J Exp Med. 137:1973;1511-1525.
48. Byrne JA, Oldstone MBA. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol. 51:1984;682-686.
49. Assmann-Wischer U, Simon MM, Lehmann-Grube F. Mechanism of recovery from acute infection. III. Subclass of T lymphocytes mediating clearance of lymphocytic choriomeningitis virus from spleens of mice. Med Microbiol Immunol. 174:1985;249-256.